Just 22% of Medicare Part D plans achieved robust generic drug substitution rates for very high cost drugs in an analysis of 2017 plans conducted by Avalere for the Association for Accessible Medicines.
Released on 23 January, the analysis looked at the number of plans with generic substitution rates of over 75% for brands that cost more than $100,000 and had generic competition....